Oncogenic KRAS modulates mitochondrial metabolism in human colon cancer cells by inducing HIF-1α and HIF-2α target genes.
about
BRAT1 deficiency causes increased glucose metabolism and mitochondrial malfunctionRedox control of glutamine utilization in cancerCombination therapy for renal cell cancer: what are possible options?PCK2 activation mediates an adaptive response to glucose depletion in lung cancerArginine ADP-ribosyltransferase 1 promotes angiogenesis in colorectal cancer via the PI3K/Akt pathwayInduction of mitochondrial dysfunction as a strategy for targeting tumour cells in metabolically compromised microenvironments.Gene regulation, modulation, and their applications in gene expression data analysisThe complex landscape of pancreatic cancer metabolismEpigenetic control of hypoxia inducible factor-1α-dependent expression of placental growth factor in hypoxic conditions.RAGE is essential for oncogenic KRAS-mediated hypoxic signaling in pancreatic cancerIdentification of novel mutations by exome sequencing in African American colorectal cancer patientsMonoacylglycerol lipase exerts dual control over endocannabinoid and fatty acid pathways to support prostate cancer.The anti-proliferative effect of L-carnosine correlates with a decreased expression of hypoxia inducible factor 1 alpha in human colon cancer cells.Can we develop effective combination antiangiogenic therapy for patients with hepatocellular carcinoma?The awakening of an advanced malignant cancer: an insult to the mitochondrial genomeMultidimensional Screening Platform for Simultaneously Targeting Oncogenic KRAS and Hypoxia-Inducible Factors Pathways in Colorectal CancerCancer cell growth and survival as a system-level property sustained by enhanced glycolysis and mitochondrial metabolic remodelingDeciphering the Key Features of Malignant Tumor Microenvironment for Anti-cancer TherapyThe role of hypoxia-inducible factor-2 in digestive system cancers.Differential network analysis reveals the genome-wide landscape of estrogen receptor modulation in hormonal cancersDeconvoluting the context-dependent role for autophagy in cancerHypoxic and Ras-transformed cells support growth by scavenging unsaturated fatty acids from lysophospholipids.Vitamin C uncouples the Warburg metabolic switch in KRAS mutant colon cancer.Adrenomedullin is a therapeutic target in colorectal cancer.KRas, ROS and the initiation of pancreatic cancerMetabolic alterations in cancer cells and therapeutic implications.Glutamine-driven oxidative phosphorylation is a major ATP source in transformed mammalian cells in both normoxia and hypoxia.Mitochondrial DNA copy number in colorectal cancer: between tissue comparisons, clinicopathological characteristics and survival.The Critical Impact of HIF-1a on Gastric Cancer Biology.Tumor suppression and promotion by autophagyKinase suppressor of ras 1 (KSR1) regulates PGC1α and estrogen-related receptor α to promote oncogenic Ras-dependent anchorage-independent growthLipid sensing by mTOR complexes via de novo synthesis of phosphatidic acid.
P2860
Q24301506-ADD894B4-13D0-4176-9736-02DC3E4D01A6Q27005615-1C6C2F90-2123-4ED1-A57E-759B7DB54BC6Q27011663-4E6607AA-D028-447A-BD20-BD1B1ED92102Q28235954-7E3F60DD-010D-4D4C-A182-0383710D0D7CQ28388238-C254D004-A540-4F96-B074-BD3388ADE64AQ30442799-72601101-AB1A-42E8-92D7-65F6E8EF6155Q30614377-CE0D1D80-BEA2-47C9-8E7B-BED6808B9E87Q33827703-51F42024-9F5D-42EB-9447-8D5FB6CF7604Q34000432-18C8FC6C-50B4-497A-A17B-F493787ED20AQ34541682-E30D0643-C255-415C-815E-8330F4CE4953Q34977426-5E22FECF-8DFF-4A45-80EA-01AC64A8C779Q35146525-A518BBE4-1FF2-4474-98DF-0DBAA412D276Q35164344-43CA309A-6E2F-4CFB-99B0-7EF3D12ADF51Q35230282-AF10F1E2-004C-4975-BE8C-8568193463B3Q35718294-B91CFE90-4081-4C4E-8407-21DB83A7B3A6Q35944520-08A46FE4-E7D9-4027-95AB-A08E0DFA7971Q36228895-62096455-95C6-40D9-A482-4AB720BD9E4BQ36284940-49B800D9-AA6C-4AA3-9071-1E2B16E787E0Q36347140-074D1488-8194-4F2C-BFA5-22A8E161BAA1Q36682166-F1B16D3B-5383-4F74-9CBE-82410246263DQ36876716-8DCD00F1-2531-46F2-816B-5F1EB7C08D90Q36895786-2A93CE6B-18BA-4A4C-915B-47623AB2B379Q37565338-6B7121E4-A49B-4B72-92E5-4DCA05D45986Q37593331-1E61992B-0A56-4520-9973-18BA8C97B62BQ37673906-AAD3F3D8-7F47-4F62-AA92-BE4A99E84E96Q37908233-D0D01286-5D4D-4285-907E-756FC911A9A2Q39049785-05662080-AE5D-42F3-AA0C-22231FBB6046Q41206635-CC519F12-E707-4075-A6F9-D8CF2E7B4AE0Q41779542-05AD682A-354E-47C3-8966-7D24DD73CB2EQ42136875-205EFED4-B1BA-4B99-ACC2-5A5BCA23E6E9Q42237844-4744E3A1-7F52-4631-A76F-4741E2594A47Q51128476-09395E8F-6CA6-4152-A488-45AFB114365A
P2860
Oncogenic KRAS modulates mitochondrial metabolism in human colon cancer cells by inducing HIF-1α and HIF-2α target genes.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Oncogenic KRAS modulates mitoc ...... IF-1α and HIF-2α target genes.
@ast
Oncogenic KRAS modulates mitoc ...... IF-1α and HIF-2α target genes.
@en
Oncogenic KRAS modulates mitoc ...... IF-1α and HIF-2α target genes.
@nl
type
label
Oncogenic KRAS modulates mitoc ...... IF-1α and HIF-2α target genes.
@ast
Oncogenic KRAS modulates mitoc ...... IF-1α and HIF-2α target genes.
@en
Oncogenic KRAS modulates mitoc ...... IF-1α and HIF-2α target genes.
@nl
prefLabel
Oncogenic KRAS modulates mitoc ...... IF-1α and HIF-2α target genes.
@ast
Oncogenic KRAS modulates mitoc ...... IF-1α and HIF-2α target genes.
@en
Oncogenic KRAS modulates mitoc ...... IF-1α and HIF-2α target genes.
@nl
P2093
P2860
P356
P1433
P1476
Oncogenic KRAS modulates mitoc ...... IF-1α and HIF-2α target genes.
@en
P2093
Craig Johnson
Duyen T Dang
Joseph G Washburn
Long H Dang
Marcia R Cruz-Correa
Sang Y Chun
P2860
P2888
P356
10.1186/1476-4598-9-293
P577
2010-11-13T00:00:00Z
P5875
P6179
1001211156